QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
QQQ   294.47 (+1.41%)
AAPL   115.17 (+1.16%)
MSFT   213.86 (+1.78%)
FB   276.92 (+3.16%)
GOOGL   1,763.90 (+2.10%)
AMZN   3,118.06 (+0.63%)
TSLA   555.38 (+6.43%)
NVDA   518.31 (-1.39%)
BABA   279.96 (+3.65%)
CGC   26.97 (+9.10%)
GE   10.45 (+3.77%)
MU   63.95 (-0.36%)
AMD   85.07 (-0.28%)
T   29.23 (+2.13%)
NIO   53.51 (-3.38%)
F   9.45 (+6.66%)
ACB   9.23 (+28.55%)
NFLX   482.88 (+1.31%)
GILD   60.25 (+0.60%)
BA   218.49 (+3.29%)
DIS   151.49 (+3.77%)
Log in
NYSE:NTR

Nutrien Stock Forecast, Price & News

$48.08
+1.49 (+3.20 %)
(As of 11/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$46.80
Now: $48.08
$48.87
50-Day Range
$38.40
MA: $41.42
$46.59
52-Week Range
$23.85
Now: $48.08
$49.23
Volume2.15 million shs
Average Volume1.74 million shs
Market Capitalization$27.36 billion
P/E Ratio282.82
Dividend Yield3.86%
Beta0.83
Nutrien Ltd. provides crop inputs and services. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating approximately 2,000 retail locations. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Read More
Nutrien logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.7Dividend Strength: 0.8Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.52 out of 5 stars


Industry, Sector and Symbol

Industry Agricultural chemicals
Sub-IndustryN/A
CUSIPN/A
Phone306-933-8500
Employees22,300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$20.02 billion
Cash Flow$6.69 per share
Book Value$38.69 per share

Profitability

Net Income$992 million

Miscellaneous

Market Cap$27.36 billion
Next Earnings Date2/16/2021 (Estimated)
OptionableOptionable
$48.08
+1.49 (+3.20 %)
(As of 11/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NTR News and Ratings via Email

Sign-up to receive the latest news and ratings for NTR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Nutrien (NYSE:NTR) Frequently Asked Questions

How has Nutrien's stock price been impacted by Coronavirus?

Nutrien's stock was trading at $32.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, NTR stock has increased by 50.3% and is now trading at $48.08.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Nutrien?

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 7 hold ratings, 12 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Nutrien
.

What stocks does MarketBeat like better than Nutrien?

Wall Street analysts have given Nutrien a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Nutrien wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Nutrien's next earnings date?

Nutrien is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Nutrien
.

How were Nutrien's earnings last quarter?

Nutrien Ltd. (NYSE:NTR) released its quarterly earnings results on Monday, November, 2nd. The company reported $0.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.16. The business earned $4.21 billion during the quarter, compared to analysts' expectations of $3.83 billion. Nutrien had a net margin of 0.47% and a return on equity of 4.19%. Nutrien's revenue for the quarter was up .9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.24 EPS.
View Nutrien's earnings history
.

How often does Nutrien pay dividends? What is the dividend yield for Nutrien?

Nutrien declared a quarterly dividend on Monday, August 10th. Investors of record on Wednesday, September 30th will be given a dividend of $0.45 per share on Friday, October 16th. This represents a $1.80 dividend on an annualized basis and a yield of 3.74%. The ex-dividend date is Tuesday, September 29th.
View Nutrien's dividend history
.

What guidance has Nutrien issued on next quarter's earnings?

Nutrien updated its FY 2020 After-Hours earnings guidance on Monday, November, 2nd. The company provided EPS guidance of 1.60-1.85 for the period.

What price target have analysts set for NTR?

20 analysts have issued 12 month target prices for Nutrien's shares. Their forecasts range from $40.00 to $55.00. On average, they anticipate Nutrien's share price to reach $46.47 in the next twelve months. This suggests that the stock has a possible downside of 3.3%.
View analysts' price targets for Nutrien
.

Are investors shorting Nutrien?

Nutrien saw a decline in short interest in October. As of October 15th, there was short interest totaling 4,070,000 shares, a decline of 26.1% from the September 30th total of 5,510,000 shares. Based on an average trading volume of 1,520,000 shares, the short-interest ratio is currently 2.7 days. Currently, 0.7% of the company's shares are sold short.
View Nutrien's Short Interest
.

Who are some of Nutrien's key competitors?

What other stocks do shareholders of Nutrien own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Who are Nutrien's key executives?

Nutrien's management team includes the following people:
  • Mr. Charles Victor Magro B.Sc. (Chem), MBA, Pres, CEO & Exec. Director (Age 50, Pay $3.12M)
  • Mr. Pedro Farah, Exec. VP & CFO
  • Mr. Michael J. Frank, Exec. VP & CEO of Retail (Age 56, Pay $1.7M)
  • Mr. Raef M. Sully, Exec. VP and CEO of Phosphate & Nitrogen (Age 53, Pay $1.06M)
  • Mr. Kenneth A. Seitz, Exec. VP & CEO of Potash (Age 51, Pay $2.5M)
  • Mr. Brent D. Poohkay, Exec. VP & Chief Information Officer (Age 50)
  • Mr. Michael R. Webb, Exec. VP and Chief HR & Admin. Officer
  • Mr. Richard Downey, VP of Investor & Corp. Relations
  • Ms. Noralee M. Bradley, Exec. VP & Chief Legal Officer
  • Mr. Kevin James Graham, Exec. VP & Pres of Sales (Age 42)

What is Nutrien's stock symbol?

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Who are Nutrien's major shareholders?

Nutrien's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Jarislowsky Fraser Ltd (2.43%), Arrowstreet Capital Limited Partnership (1.64%), TD Asset Management Inc. (1.56%), Black Creek Investment Management Inc. (1.54%), CIBC Asset Management Inc (1.46%) and Great West Life Assurance Co. Can (1.29%).

Which institutional investors are selling Nutrien stock?

NTR stock was sold by a variety of institutional investors in the last quarter, including TD Asset Management Inc., Boston Partners, The Manufacturers Life Insurance Company, Letko Brosseau & Associates Inc., Morgan Stanley, Cidel Asset Management Inc., Great West Life Assurance Co. Can, and JPMorgan Chase & Co..

Which institutional investors are buying Nutrien stock?

NTR stock was acquired by a variety of institutional investors in the last quarter, including Vaughan Nelson Investment Management L.P., Thrivent Financial for Lutherans, Toronto Dominion Bank, Great West Life Assurance Co. Can, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Arrowstreet Capital Limited Partnership, Artemis Investment Management LLP, and Epoch Investment Partners Inc..

How do I buy shares of Nutrien?

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Nutrien's stock price today?

One share of NTR stock can currently be purchased for approximately $48.08.

How big of a company is Nutrien?

Nutrien has a market capitalization of $27.36 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

What is Nutrien's official website?

The official website for Nutrien is www.nutrien.com.

How can I contact Nutrien?

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]

This page was last updated on 11/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.